Cheng Zhang

Cheng Zhang

Auto-generated profile, based on publicly available information

Cheng Zhang

State Key Laboratory of Food Science and Technology, School of Food Science and Technology, Jiangnan University, Wuxi, People’s Republic of China

Research Focus & Metrics

Academic Career Length

6Years (2021-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
5 January 2022 in Phytochemistry Reviews
Verified
Journal Article
Closed access
PDF file
YLYingjie Liu
Yingjie Liu
JWJieyu Wang
Jieyu Wang
LWLu Wang
Lu Wang
CZCheng Zhang
Cheng Zhang
QBQingxiang Bai
Qingxiang Bai
RYRuijin Yang
Ruijin Yang

16 December 2021 in Frontiers in Oncology
Verified
Journal Article
Open access
ZLZhendong Liu
Zhendong Liu
ZRZhishuai Ren
Zhishuai Ren
CZCheng Zhang
Cheng Zhang
RQRongjun Qian
Rongjun Qian
HWHongbo Wang
Hongbo Wang
YGYanzheng Gao
Yanzheng Gao
ETS transcription factor ELK3 (ELK3), a novel oncogene, affects pathological processes and progression of many cancers in human tissues. However, it remains unclear whether ELK3, as a key gene, affects the pathological process of gliomas and the prognosis of patients with gliomas. This study aimed to comprehensively and systematically reveal the correlation between ELK3 and the malignant progression of gliomas by analyzing clinical sample information stored in multiple databases. We revealed the putative mechanism of ELK3 involvement in malignant gliomas progression and identified a new and efficient biomarker for glioma diagnosis and targeted therapy. Based on the sample data from multiple databases and real-time quantitative polymerase chain reaction (RT-qPCR), the abnormally high expression of ELK3 in gliomas was confirmed. Kaplan-Meier and Cox regression analyses demonstrated that a high ELK3 expression was markedly associated with low patient survival and served as an independent biomarker of gliomas. Wilcox and Kruskal-Wallis tests revealed that expression of ELK3 was positively correlated with several clinical characteristics of patients with gliomas, such as age, WHO classification, and recurrence. Moreover, Cell Counting Kit‐8 (CCK-8), immunofluorescence, and wound healing assays confirmed that ELK3 overexpression markedly promoted the proliferation and migration of glioma cells. Finally, gene set enrichment analysis (GSEA) and western blotting confirmed that overexpression of ELK3 regulated the JAK–STAT signaling pathway and upregulate the expression of signal transducer and activator of transcription 3 (STAT3) and phosphorylated STAT3 (P-STAT3) to promote the malignant transition of gliomas. Therefore, ELK3 may serve as an efficient biomarker for the diagnosis and prognosis of gliomas and it can also be used as a therapeutic target to improve the poor prognosis of patients with gliomas.

7 October 2021
Verified
Conference Paper
Closed access
JWJing Wang
Jing Wang
PCPing Chen
Ping Chen
CZCheng Zhang
Cheng Zhang
YKYi Kang
Yi Kang
Corona virus disease 2019 (COVID-19) is a kind of acute infectious pneumonia that causes dyspnea and slow breathing for severe patients. Since respiratory cycle can be analyzed for auxiliary diagnosis, an automatic respiratory detection system can replace a stethoscope for measuring a patients' respiratory cycle in the isolation ward, which ensures real-time monitoring. In this paper, we propose a convolutional neural network (CNN) model that can effectively detect the cycle of breath sounds in COVID-19 patients. The Mel-spectrogram features were extracted from the data collected from hospital patients, and convolutional neural network is then used for training. After testing in different cases, the result shows that the sensitivity of this method is 90.03%, and the average accuracy is 91.32%.